ANEST IWATA Corp. (6381) AI Stock Analysis

• Market Cap: ¥61.44B
• Dividend Yield: 2.88%
• Average Volume (3M): 71.42K
• Price to Earnings (P/E): 14.8
• Beta (1Y): 0.74
• Revenue Growth: 0.52%
• EPS Growth: -8.88%
• Country: JP
• Employees: 1,865
• Sector: Industrials
• Sector Strength: 80
• Industry: Industrial - Machinery
• EPS (TTM): 22.77
• Shares Outstanding: 41,745,502
• 10 Day Avg. Volume: 79,720
• 30 Day Avg. Volume: 71,420
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,729.00
• Price Target Upside: 10.83% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 74 Outperform
• Price Target: ¥1,729.00 ▲(10.83% Upside)

ANEST IWATA Corp.'s overall stock score is primarily driven by its strong financial performance, characterized by robust revenue growth, profitability, and cash flow generation. Technical analysis suggests bullish momentum, although caution is advised due to overbought signals. Valuation metrics are reasonable, providing additional support to the stock's attractiveness.

ANEST IWATA Corp. Business Overview & Revenue Model

Company Description

ANEST IWATA Corp. is a leading Japanese manufacturer specializing in producing high-quality air compressors, coating equipment, and vacuum pumps. The company serves a wide range of industries, including automotive, industrial machinery, and construction. Known for its innovative technology and commitment to sustainability, ANEST IWATA offers products that enhance productivity and efficiency for businesses worldwide.

How the Company Makes Money

ANEST IWATA Corp. generates revenue primarily through the sale of its air compressors, coating equipment, and vacuum pumps. The company's revenue streams are diversified across various sectors, including automotive, industrial manufacturing, and construction, which require reliable and efficient equipment. Additionally, ANEST IWATA benefits from strong partnerships with distributors and OEMs, expanding its market reach globally. After-sales services and maintenance contracts also contribute to the company's revenue, ensuring continued customer engagement and product lifecycle support.

ANEST IWATA Corp. Financial Statement Overview

Summary

ANEST IWATA Corp. exhibits solid financial health with strong revenue growth, profitability, and cash flow generation. The company is well-positioned with a strong balance sheet characterized by low leverage and a high equity ratio, reducing financial risk. Continued focus on efficient operations and cash flow management will further enhance its financial strength.

Income Statement

ANEST IWATA Corp. shows a strong gross profit margin of 46.54% for the most recent year. The net profit margin for the same period is 7.86%, indicating effective cost control. Revenue growth has been consistent, with a 1.85% increase from the previous year. EBIT and EBITDA margins are solid at 10.85% and 18.13%, respectively, highlighting efficient operations and strong earnings before interest, tax, depreciation, and amortization.

Balance Sheet

The company maintains a low debt-to-equity ratio of 0.06, implying low financial leverage and risk. The return on equity stands at 9.13%, reflecting good profitability relative to equity. An equity ratio of 67.70% indicates a strong capital structure, with significant equity financing supporting overall financial stability.

Cash Flow

ANEST IWATA Corp. reports a robust free cash flow growth rate of 53.83% year-over-year, demonstrating efficient cash generation. An operating cash flow to net income ratio of 2.28 signifies strong cash flow from operations relative to net income. The free cash flow to net income ratio is 1.66, indicating healthy cash flow available after capital expenditures.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	54.41B	53.42B	48.52B	42.34B	35.59B
Gross Profit	25.32B	24.48B	21.34B	18.23B	14.93B
EBITDA	9.86B	10.31B	9.23B	7.36B	5.83B
Net Income	4.28B	4.93B	4.38B	3.54B	2.62B
Balance Sheet
Total Assets	69.20B	66.14B	60.14B	55.82B	49.46B
Cash, Cash Equivalents and Short-Term Investments	21.34B	16.93B	14.51B	14.32B	13.20B
Total Debt	2.87B	3.07B	2.67B	2.42B	2.47B
Total Liabilities	15.64B	16.07B	14.88B	15.61B	13.32B
Stockholders Equity	46.85B	44.16B	40.03B	35.62B	32.24B
Cash Flow
Free Cash Flow	7.08B	4.60B	2.16B	2.45B	3.84B
Operating Cash Flow	9.75B	6.77B	4.33B	3.89B	4.60B
Investing Cash Flow	-3.25B	-1.26B	-3.32B	-1.08B	-1.07B
Financing Cash Flow	-3.93B	-3.58B	-2.36B	-2.10B	-1.96B

ANEST IWATA Corp. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1560.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6381, the sentiment is Positive. The current price of 1560 is below the 20-day moving average (MA) of 1560.55, above the 50-day MA of 1471.16, and above the 200-day MA of 1341.02, indicating a neutral trend. The MACD of 25.32 indicates Positive momentum. The RSI at 61.02 is Neutral, neither overbought nor oversold. The STOCH value of 30.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6381.

ANEST IWATA Corp. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6364	82 Outperform	¥59.09B	13.03		2.78%	2.79%	-14.83%
6517	82 Outperform	¥59.30B	12.61		2.49%	-6.68%	-11.92%
6333	81 Outperform	¥51.80B	14.30		3.27%	1.90%	36.12%
6381	74 Outperform	¥61.44B	14.79		2.88%	0.52%	-8.88%
6237	73 Outperform	¥55.40B	12.73		2.49%	2.55%	1.34%
6363	66 Neutral	¥54.26B	22.23		2.90%	9.31%	-62.88%
Sector *	58 Neutral	HK$13.99B	4.55	-2.78%	5.71%	2.20%	-57.37%

ANEST IWATA Corp. Corporate Events

ANEST IWATA Unveils New Medium-Term Business Plan

ANEST IWATA Corporation has announced the formulation of a new medium-term business plan covering fiscal years 2026 to 2028. This strategic plan is expected to guide the company’s operations and potentially enhance its market position by aligning its goals with future industry trends and stakeholder expectations.

ANEST IWATA Announces Dividend Distribution for Fiscal Year 2025

ANEST IWATA Corporation announced a resolution to distribute dividends of surplus, with a record date of March 31, 2025. The dividend per share is set at 23.00 yen, resulting in a total annual dividend of 45.00 yen per share, a decrease from the previous year’s 49.00 yen. This decision aligns with the company’s policy of maintaining a stable return of profits to shareholders, targeting a consolidated dividend payout ratio of 40%. The payout ratio for this fiscal year is 41.6%, reflecting the company’s commitment to balancing shareholder returns with business performance considerations.

ANEST IWATA Corp. Reports FY2024 Results and Unveils New Business Plan

ANEST IWATA Corp. reported a 1.8% increase in net sales for FY2024, driven by a sales recovery in Japan and expanded coating equipment sales in Europe. However, operating profit slightly decreased due to higher overseas expenses and a weaker yen. The company has initiated a new medium-term business plan aiming to boost revenue across all regions, with a focus on air compressors. Despite an expected decline in profit due to rising personnel costs and investments, ANEST IWATA plans to enhance shareholder returns through dividends and share buybacks.

ANEST IWATA Reports FY2024 Financial Results with Strategic Adjustments

ANEST IWATA Corporation reported its FY2024 financial results, showing a slight increase in net sales by 1.8% to 54,411 million yen, but a decrease in operating profit by 4.4% and ordinary profit by 10.6%. The company also announced changes in its consolidation scope, including the addition of ANEST IWATA A.I.R. Philippines Inc. and the exclusion of ANEST IWATA Italia S.r.l. Despite challenges, the company maintains a strong equity ratio and plans to increase dividends in FY2025, indicating confidence in future growth.